Short Wave Short Wave

This gas station drug acts like opioids. It’s getting harder to buy

Nov 20, 2026 · 14m

Summary

NPR science reporter Rachel Carlson explores the growing market for Kratom and 7-OH products, which are sold as pain relief or opioid withdrawal aids but carry significant addiction risks. The episode features personal stories from users who developed severe dependencies, alongside expert insights on the dangers of unregulated, poorly labeled substances. It also covers recent DEA moves to restrict specific semi-synthetic derivatives, highlighting the ongoing tension between public health concerns and the lack of federal oversight for natural Kratom.

Topics discussed

Sponsor: Citi Premium Boost Introduction to Kratom and 7-OH products Tyler's story: Using Kratom for opioid withdrawal Tyler's experience with 7-OH tablets and addiction Episode overview and host introductions Sponsors: Whole Foods, Citi, and Open Door Reflection on Tyler's detox and accessibility Brian's story: Discovering Kratom at a gas station Brian's transition to 7-OH and addiction Angela's positive experience managing pain Scientific perspective on addiction patterns The high cost of 7-OH usage Rising poison control calls and deaths Concerns over labeling and product dosing Federal regulation and DEA restrictions Pushback from users and industry lobbying Credits and closing remarks Sponsor: Schwab Sponsor: Prolon

More from Short Wave

How a viral video gave a huge boost to new gene therapy
Nov 18, 2026
How bird poop and manta rays sustain a pristine coral reef
Nov 17, 2026
Are your body clocks off? Meet ‘circadian depression’
Nov 16, 2026
AI could help hospitals diagnose PTSD in real time
Nov 13, 2026
Can scientists reverse your age?
Nov 11, 2026
Listen ad-free on Castria